Trial Profile
The explorative clinical trial of a HPV therapeutic vaccine using lactobacillus to Cervical Intraepithelial Neoplasia 3 (CIN3).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Cervical cancer; Cervical dysplasia; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2012 Result were presented in an AnGes MG media release.
- 29 Nov 2011 New trial record